CAS 1589503-30-9

Afasevikumab

CAS : 1589503-30-9

Anti-IL17A/IL17F monoclonal antibody; possible use as a treatment of inflammatory diseases

Ref: 3D-CLA1407

Afasevikumab

CAS : 1589503-30-9

Afasevikumab (RG 7624) is a fully humanised monoclonal antibody that targets and neutralises IL-17A and IL-17F,autoimmune diseases and inflammation.

Degré de pureté : 95%

Couleur et forme : Liquid

Masse moléculaire : 146.07 kDa

Ref: TM-T76901